Driving innovation in regenerative medicine: €37.5 million grant for DRIVE-RM consortium

FHS
May 24, 2024
2:06 pm

The DRIVE-RM consortium, led by Professor of Experimental Nephrology Marianne Verhaar from UMC Utrecht, has been awarded €37.5 million under the prestigious NWO SUMMIT program.

Is the Business of Healthcare Out of Control? Optimize Time and Reduce Administrative Burden with AI

Amy Brown, founder and CEO of Authenticx Juggling the administrative business of a complex healthcare system with administering patient care is an undeniable challenge. Healthcare

June 25, 2024

Mainz Biomed N.V. Regains Compliance with Nasdaq Capital Market Listing Requirements – Biotech Investments

Issuer: Mainz BioMed N.V. / Key word(s): Miscellaneous 27.01.2025 / 14:01 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed

January 28, 2025

New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show

Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among patients with relapsed or refractory B-cell acute lymphoblastic leukemia

November 28, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.